Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome
Open Access
- 19 March 2014
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 276 (6) , 651-658
Abstract
Objective: The soluble urokinase plasminogen activator receptor (suPAR) reflects inflammation. However, the prognostic value of suPAR measurements, particularly at the very early onset of systemic inflammatory response syndrome (SIRS), is less well defined.Methods: The prognostic potential of suPAR levels in patients with SIRS was evaluated. From November 2010 until April 2013, 902 adult patients presenting with SIRS were investigated. Blood samples for laboratory testing of inflammation markers were collected simultaneously with initial blood cultures. suPAR testing was performed using suPARnostic© assay.Results: Analyses of receiver operating characteristics curves revealed areas under the curve (AUCs) of 0.818 for predicting overall mortality within 48 h (36/902 patients died), 0.739 for 30‐day mortality (117/902 died) and 0.706 for predicting 90‐day mortality (151/902 died). AUCs for procalcitonin (0.777, 0.671 and 0.638), interleukin‐6 (0.709, 0.593 and 0.569) and C‐reactive protein (0.66, 0.594 and 0.586) as well as renal function and age were markedly lower. Using multivariable regression analyses, suPAR levels (P < 0.001) remained significant predictors of 48‐h mortality, whereas suPAR levels (P < 0.001) and bacteraemia (P = 0.002 and P = 0.001, respectively) remained significant predictors of 30‐ and 90‐day mortality. Using Kaplan–Meier survival plots, patients with suPAR −1 at SIRS onset had a clear benefit.Conclusion: suPAR plasma level determined at early SIRS is predictive for mortality.Keywords
This publication has 23 references indexed in Scilit:
- Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remissionClinical Chemistry and Laboratory Medicine (CCLM), 2012
- Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic reviewIntensive Care Medicine, 2012
- The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndromeClinical Biochemistry, 2011
- Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patientsCritical Care, 2011
- suPAR associates to glucose metabolic aberration during glucose stimulation in HIV-infected patients on HAARTJournal of Infection, 2008
- Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factorEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective studyCritical Care, 2007
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992